Apurva Chonkar

Apurva Chonkar has extensive experience in various roles within the pharmaceutical industry. Apurva is currently serving as the Associate Director - Cancer Biology at Mariana Oncology, where they have been working since 2022. Prior to this, they worked as a Senior Scientist II at Mariana Oncology from 2022 to 2023.

Before joining Mariana Oncology, Apurva held positions at Skyhawk Therapeutics, Third Rock Ventures, FORMA Therapeutics, Inc., Acetylon Pharmaceuticals, Inc., Dana-Farber Cancer Institute, King's College London, Health Protection Agency, London, UK, and the University of Central Lancashire.

At Skyhawk Therapeutics, they worked as a Scientist I from 2021 to 2022 and as a Principal Associate Scientist from 2019 to 2022. At Third Rock Ventures, they worked as a Consultant in 2019.

Apurva's work experience also includes roles at FORMA Therapeutics, Inc. as a Principal Research Associate from 2018 to 2019 and as a Senior Research Associate from 2016 to 2017. Apurva worked as an Associate Scientist (preclinical Development) at Acetylon Pharmaceuticals, Inc. from 2013 to 2016.

Earlier in their career, they gained experience at the Dana-Farber Cancer Institute as a Senior Research Associate in the field of oncology from 2011 to 2014. Apurva also worked at King's College London as a Senior Clinical Research Coordinator in the Blood Sciences group from 2009 to 2010.

Apurva began their career as a Healthcare Scientist at the Health Protection Agency, London, UK in 2008 and as a Laboratory Demonstrator at the University of Central Lancashire from 2006 to 2008.

Apurva Chonkar has a Master of Science (MS) degree in Biomedical Sciences, General from the University of Central Lancashire. They also have a Bachelor of Science degree in Biomedical Sciences, General from the same university.